GAIL BOUDREAUX
CIK 1287920 · President and CEO · last filed 2026-03-13
GAIL BOUDREAUX is a President and CEO who has filed 139 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for TGT, was dated Mar 13, 2026. Across all open-market trades the lifetime net is −$37.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $68.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$68.48M
9
139
-$37.02M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TGT | Director | 12,192 | $135.23 | $1.65M | $0 | 6 | 2026-03-13 |
| ELV | President and CEO | 160,520 | $404.07 | $64.86M | -$14.59M | 7 | 2026-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | President and CEO | 94,041 | $482.58 | $45.38M | $2.00M | 6 | 2022-03-03 |
| ZIMMER BIOMET HOLDINGS, INC. (ZMHw) Delisted | Director | 2,095 | — | — | $250.0K | 41 | 2021-04-02 |
| ANTX | President and CEO | 11,104 | $4.74 | $52.6K | $0 | 1 | 2018-03-05 |
| XEL | Director | 1,780 | $79.22 | $141.0K | $50.0K | 29 | 2018-01-02 |
| NVAX | Director | 200,000 | $8.88 | $1.78M | $144.8K | 4 | 2017-03-20 |
| UNITEDHEALTH GROUP INC (UNHw) Delisted | EVP & CEO, UnitedHealthcare | 184,731 | — | — | -$24.88M | 39 | 2014-09-25 |
| GENZYME CORP (GENZ) Delisted | Director | 5,000 | — | — | $0 | 6 | 2011-04-06 |
Recent Filings
139 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-13 | TGT | Grant (A) | +2,682 | $0 | EDGAR |
| 2026-03-04 | ELV | Mixed | +18,231 | -$2.47M | EDGAR |
| 2025-07-18 | ELV | Buy (P) | +8,500 | $2.44M | EDGAR |
| 2025-03-14 | TGT | Grant (A) | +2,946 | $0 | EDGAR |
| 2025-03-05 | ELV | Mixed | +15,811 | -$4.11M | EDGAR |
| 2024-07-23 | ELV | Sell (S) | −34,000 | -$17.03M | EDGAR |
| 2024-03-15 | TGT | Grant (A) | +1,873 | $0 | EDGAR |
| 2024-03-05 | ELV | Mixed | +23,676 | -$9.61M | EDGAR |
| 2023-03-10 | TGT | Grant (A) | +1,902 | $0 | EDGAR |
| 2023-03-03 | ELV | Mixed | +24,212 | -$9.42M | EDGAR |